| Name | Title | Contact Details |
|---|
Covalent Medical Inc is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies. Build a portfolio of market-leading medical device companies comprised of FDA approved, high revenue-generating technologies and products from the largest market opportunity segments and emerging research and development technologies.
Laboratorie Dentachrome is a Quebec, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SuperSonic Imagine designs, develops and markets a new generation ultrasound system, Aixplorer, with an UltraFast platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate.
Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.